Related references
Note: Only part of the references are listed.Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents
Yasmine Alyassin et al.
DRUG DISCOVERY TODAY (2020)
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs
Jeremy Beguin et al.
BMC VETERINARY RESEARCH (2020)
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
Jeremy Beguin et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database
Laurent Arnaud et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
Johann Foloppe et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Liposome-encapsulated chemotherapy: Current evidence for its use in companion animals
B. Borresen et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas
Kim Menard et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Pre-Existing Liver Disease and Toxicity of Antifungals
Nikolaos Spernovasilis et al.
JOURNAL OF FUNGI (2018)
The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats
Katarzyna Zabielska-Koczywas et al.
MOLECULES (2017)
Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1
[Anonymous]
VETERINARY AND COMPARATIVE ONCOLOGY (2016)
Mucocutaneous lupus erythematosus in dogs (21 cases)
Thierry Olivry et al.
VETERINARY DERMATOLOGY (2015)
Drug Hypersensitivity Reactions Targeting the Skin in Dogs and Cats
K. L. Voie et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine
Aaron Tan et al.
NANOMEDICINE (2011)
Clinical Pharmacokinetics of Oral Controlled-Release 5-Fluorocytosine
Manjunath P. Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Chris Oerlemans et al.
PHARMACEUTICAL RESEARCH (2010)
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
NK Green et al.
GENE THERAPY (2004)
Use of cisplatin, 5-fluorouracil, and second-look laparotomy for the management of gastrointestinal adenocarcinoma in three dogs
RM Stanclift et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2004)
Adjuvant post-operative chemotherapy in bitches with mammary cancer
M Karayannopoulou et al.
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE (2001)
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
A Vermes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Flucytosine: Correlation between toxicity and pharmacokinetic parameters
A Vermes et al.
CHEMOTHERAPY (2000)
Share Paper
